Biblio

Author Title [ Type

] Year

Filters: Author is Chiappella, Annalisa [Clear All Filters]

Journal Article

Chiappella A, Casadei B, Chiusolo P, Di Rocco A, Ljevar S, Magni M, Angelillo P, Barbui AMaria, Cutini I, Dodero A, et al. Axicabtagene ciloleucel treatment is more effective in primary mediastinal large B-cell lymphomas than in diffuse large B-cell lymphomas: the Italian CART-SIE study. Leukemia. 2024.

Rusconi C, Cheah CY, Eyre TAndrew, Tucker DL, Klener P, Giné E, Crucitti L, Muzi C, Iadecola S, Infante G, et al. Ibrutinib improves survival compared to chemotherapy in mantle cell lymphoma with central nervous system relapse. Blood. 2022.

Vegliante MCarmela, Mazzara S, Zaccaria GMaria, De Summa S, Esposito F, Melle F, Motta G, Sapienza MRosaria, Opinto G, Volpe G, et al. NR1H3 (LXRα) IS ASSOCIATED WITH PRO-INFLAMMATORY MACROPHAGES, PREDICTS SURVIVAL AND SUGGESTS POTENTIAL THERAPEUTIC RATIONALES IN DIFFUSE LARGE B-CELL LYMPHOMA. Hematol Oncol. 2022.

Chiappella A, Ladetto M. The role of autologous haematopoietic stem-cell transplantation in mantle cell lymphoma. Lancet Haematol. 2021;8(9):e617-e619.

Chiappella A, Dodero A, Evangelista A, Re A, Orsucci L, Usai SVeronica, Castellino C, Stefoni V, Pinto A, Zanni M, et al. Romidepsin-CHOEP followed by high-dose chemotherapy and stem-cell transplantation in untreated Peripheral T-Cell Lymphoma: results of the PTCL13 phase Ib/II study. Leukemia. 2023.

Chiappella A, Corradini P. Selective inhibitors of nuclear export in aggressive B-cell lymphomas. Lancet Haematol. 2020;7(7):e500-e501.